Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and PK of AZD0292 Administered IV in Participants 12 Years of Age and Older With Bronchiectasis and Chronic Pseudomonas Aeruginosa Colonization [Phase 2]

View source ↗

Summary

A Phase 2 trial to evaluate the efficacy, safety, and pharmacokinetics of intravenously administered AZD0292 in participants aged 12 years and older with bronch…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiectasis

Drugs mentioned

• AZD0292

Snippet

Sponsor: AstraZeneca | Conditions: Bronchiectasis With Pseudomonas Aeruginosa Colonization | Phase 2 | Status: RECRUITING